Clinical Trial Update: Atezolizumab Plus CArboplatin Plus Nab-paclitaxel [Phase 2]

View source ↗

Summary

Phase 2 trial investigating atezolizumab in combination with carboplatin and nab-paclitaxel for metastatic and triple-negative breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• CARBOPLATIN (Carboplatin)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Consorzio Oncotech | Conditions: Metastatic Breast Cancer, Triple Negative Breast Cancer | Phase 2 | Status: UNKNOWN